Posted on 8/14/20
3 Green Flags for Moderna's Future
The COVID-19 pandemic has presented massive new challenges for societies across the globe. So far this year, the viral disease has killed nearly 744,000 people worldwide, . . .
Posted on 8/13/20
Boston Scientific For The Long Term
SummaryBoston Scientific faces many headwinds in Q3 and Q4 2020 because the pandemic has dramatically curtailed its operations and reduced the demand for its products.The company . . .
Posted on 8/13/20
CVS Health to Hire Hundreds of New Jobs Across Arizona
In anticipation of the increased demand for influenza vaccinations and the likely ongoing presence of COVID-19 this fall, CVS Health (NYSE: CVS) announced today the hiring . . .
Posted on 8/13/20
Phio Pharmaceuticals Provides Business Update
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform, today reported its . . .
Posted on 8/13/20
Thermo Fisher Scientific to Acquire QIAGEN
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its offer to acquire all of the ordinary shares of QIAGEN . . .
Posted on 8/13/20
Seres Therapeutics Prices Public Offering of 10.5M Shares of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics platform company developing a novel class of multifunctional bacterial consortia that are designed to functionally . . .
Posted on 8/13/20
scPharmaceuticals Provides Business Update
BURLINGTON, Mass.--(BUSINESS WIRE)--scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, . . .
Posted on 8/13/20
Forma Therapeutics Provides Business Update
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today reported financial results for the second . . .
Posted on 8/13/20
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
LEXINGTON, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments . . .
Posted on 8/13/20
CVS Deep Dive: A Case To Buy Shares Now
SummaryCVS is a fully integrated healthcare provider with a leading market share in its core markets and is poised to take advantage of the secular growth . . .
Posted on 8/13/20
Moderna Stock Surges on $1.5 Billion Coronavirus Vaccine Deal with the U.S. Government
The United States of America is building its arsenal for the battle against COVID-19.The U.S. government has struck a blockbuster deal with Moderna (NASDAQ:MRNA) that will . . .
Posted on 8/12/20
Greentown Labs and Vineyard Wind Announce Offshore Wind Challenge Startup Participants
Greentown Labs, the largest climatetech startup incubator in North America, and Vineyard Wind, developer of the first utility-scale offshore wind energy generation facility in the United . . .
Posted on 8/12/20
Pediatric Therapy Services Makes the Inc. 5000 List of the Fastest Growing Companies
Pediatric Therapy Services, LLC, who operates as The Stepping Stones Group, a leading national provider of therapeutic, behavioral and autism services to children in educational and . . .
Posted on 8/12/20
Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced a research collaboration with Dartmouth-Hitchcock Health . . .
Posted on 8/12/20
Celdara Medical Announces Receipt of NIH Funding for Pandemic Influenza Antiviral Development
Celdara Medical announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Small Business Innovation Research . . .
Posted on 8/12/20
Reify Health Raises $30 Million Series B
Reify Health, provider of leading cloud-based solutions that connect and empower the clinical trial ecosystem, today announced a $30 million Series B funding round led by . . .
Posted on 8/12/20
Boston Scientific: This Healthcare Technology Company Is Poised To Thrive
The Healthcare sector has been one of the net winners so far this year. While its performance has not been as spectacular as that of the . . .
Posted on 8/12/20
Frequency Therapeutics Provides Business Updates and Reports Second Quarter 2020 Financial Results
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a . . .
Posted on 8/12/20
Cambridge Isotope Laboratories Announces Expansion of 13C Capacity at Ohio Plant
Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), recently completed a significant expansion of its 13C . . .
Posted on 8/12/20
Exicure Reports Second Quarter 2020 Financial Results and Corporate Progress
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid technology, today reported financial results for . . .
Posted on 8/12/20
TCR Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for . . .
Posted on 8/12/20
States with the Most Improved Health During COVID-19 – WalletHub Study
With states’ reopening progress being delayed due to spikes in COVID-19, WalletHub today released updated rankings for the States with the Biggest Health Improvements During COVID-19, . . .
Posted on 8/12/20
Unum Therapeutics Provides Corporate Updates
Unum Therapeutics Inc. (Nasdaq: UMRX), a biopharmaceutical company focused on developing novel, best-in-class precision kinase inhibitors for a range of patients living with cancer and other . . .
Posted on 8/12/20
Seres Therapeutics Proposes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq:MCRB), a leading microbiome therapeutics platform company developing a novel class of multifunctional bacterial consortia that are designed to functionally interact . . .
Posted on 8/11/20
Fusion Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced financial results for the second quarter ended . . .
Boston
